Healthcare stocks trimmed their previous losses ahead of Thursday’s close of trading, with the NYSE Health Care Index still down 0.7% while the Health Care Select Sector SPDR ETF (XLV) fell 0.6%.

The Nasdaq Biotechnology Index rose 1.3%.

In corporate news, STAAR Surgical (STAA) rose more than 20% after the eye implant specialist announced better-than-expected financial results for the second quarter and raised its revenue guidance for fiscal year 21. Excluding one-time items, the company earned $ 0.27 per share, compared to adjusted earnings of $ 0.03 per share for the same quarter in 2020, while revenue increased more than 77% year-over-year to $ 62.4 million Dollar rose. The Street was priced at $ 0.09 per share, or $ 52.6 million.

AdaptHealth (AHCO) climbed more than 15% after the home health device company posted a 166% year-over-year increase in sales to 617 million from $ 2.38 billion to $ 2.48 billion. Analysts were expecting an average of $ 2.3 billion in revenue this year.

Among the relegators, Nevro (NVRO) slumped 23% after second-quarter sales increased 82% to 102.3 million in the same quarter from July to September 2020. The medical device company also withdrew its guidance for fiscal year 21 and referred to the ongoing uncertainty caused by the COVID-19 pandemic.

Amedisys (AMED) slipped 22% after the home nursing and hospice company posted sales of $ 564.2 million.

Stay up to date

Subscribe to our daily morning update newsletter and don’t miss any important market news, moves and more.

You may also like